A citation-based method for searching scientific literature

Wencke Walter, Nicole Pfarr, Manja Meggendorfer, Philipp Jost, Torsten Haferlach, Wilko Weichert. Semin Cancer Biol 2022
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Identification of risk factors in atypical chronic myeloid leukemia.
Massimo Breccia, Francesca Biondo, Roberto Latagliata, Ida Carmosino, Franco Mandelli, Giuliana Alimena. Haematologica 2006
65
33

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia.
Prateek Pophali, Aasiya Matin, Abhishek A Mangaonkar, Ryan Carr, Moritz Binder, Aref Al-Kali, Kebede H Begna, Kaaren K Reichard, Hassan Alkhateeb, Mithun V Shah,[...]. Blood Cancer J 2020
10
33

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.
Lukasz P Gondek, Ramon Tiu, Christine L O'Keefe, Mikkael A Sekeres, Karl S Theil, Jaroslaw P Maciejewski. Blood 2008
247
33

Clinical effect of point mutations in myelodysplastic syndromes.
Rafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, Naomi Galili, Björn Nilsson, Guillermo Garcia-Manero, Hagop Kantarjian, Azra Raza, Ross L Levine, Donna Neuberg,[...]. N Engl J Med 2011
33

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.
Andres Jerez, Yuka Sugimoto, Hideki Makishima, Amit Verma, Anna M Jankowska, Bartlomiej Przychodzen, Valeria Visconte, Ramon V Tiu, Christine L O'Keefe, Azim M Mohamedali,[...]. Blood 2012
82
33

The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
Jason Gotlib, Julia E Maxson, Tracy I George, Jeffrey W Tyner. Blood 2013
116
33

Mutation in TET2 in myeloid cancers.
François Delhommeau, Sabrina Dupont, Véronique Della Valle, Chloé James, Severine Trannoy, Aline Massé, Olivier Kosmider, Jean-Pierre Le Couedic, Fabienne Robert, Antonio Alberdi,[...]. N Engl J Med 2009
33

Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients.
Abhishek A Mangaonkar, David M Swoboda, Giacomo Coltro, Terra L Lasho, Paul J Novotny, Prateek Pophali, Ryan M Carr, Moritz Binder, Christy M Finke, Naseema Gangat,[...]. Leukemia 2020
20
33

Genomic determinants of chronic myelomonocytic leukemia.
B J Patel, B Przychodzen, S Thota, T Radivoyevitch, V Visconte, T Kuzmanovic, M Clemente, C Hirsch, A Morawski, R Souaid,[...]. Leukemia 2017
63
33

Integrated molecular profiling of juvenile myelomonocytic leukemia.
Norihiro Murakami, Yusuke Okuno, Kenichi Yoshida, Yuichi Shiraishi, Genta Nagae, Kyogo Suzuki, Atsushi Narita, Hirotoshi Sakaguchi, Nozomu Kawashima, Xinan Wang,[...]. Blood 2018
51
33


Cytogenetic risk stratification in chronic myelomonocytic leukemia.
Esperanza Such, José Cervera, Dolors Costa, Francesc Solé, Teresa Vallespí, Elisa Luño, Rosa Collado, María J Calasanz, Jesús M Hernández-Rivas, Juan C Cigudosa,[...]. Haematologica 2011
183
33

250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.
Andrew J Dunbar, Lukasz P Gondek, Christine L O'Keefe, Hideki Makishima, Manjot S Rataul, Hadrian Szpurka, Mikkael A Sekeres, Xiao Fei Wang, Michael A McDevitt, Jaroslaw P Maciejewski. Cancer Res 2008
243
33

Age-related clonal hematopoiesis associated with adverse outcomes.
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa Manning, Peter V Grauman, Brenton G Mar, R Coleman Lindsley, Craig H Mermel, Noel Burtt, Alejandro Chavez,[...]. N Engl J Med 2014
33

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.
Anna M Jankowska, Hadrian Szpurka, Ramon V Tiu, Hideki Makishima, Manuel Afable, Jungwon Huh, Christine L O'Keefe, Rebecca Ganetzky, Michael A McDevitt, Jaroslaw P Maciejewski. Blood 2009
296
33

Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia.
Hassan Awada, Yasunobu Nagata, Abhinav Goyal, Mohammad F Asad, Bhumika Patel, Cassandra M Hirsch, Teodora Kuzmanovic, Yihong Guan, Bartlomiej P Przychodzen, Mai Aly,[...]. Blood Adv 2019
21
33

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
David P Steensma, Rafael Bejar, Siddhartha Jaiswal, R Coleman Lindsley, Mikkael A Sekeres, Robert P Hasserjian, Benjamin L Ebert. Blood 2015
994
33

Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Véronique Gelsi-Boyer, Manja Meggendorfer, Margot Morabito, Céline Berthon, Lionel Adès, Pierre Fenaux, Odile Beyne-Rauzy,[...]. J Clin Oncol 2013
371
33


Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.
Julien Broseus, Lourdes Florensa, Esther Zipperer, Susanne Schnittger, Luca Malcovati, Steven Richebourg, Eric Lippert, Jaroslav Cermak, Jyoti Evans, Morgane Mounier,[...]. Haematologica 2012
62
33

Frequent pathway mutations of splicing machinery in myelodysplasia.
Kenichi Yoshida, Masashi Sanada, Yuichi Shiraishi, Daniel Nowak, Yasunobu Nagata, Ryo Yamamoto, Yusuke Sato, Aiko Sato-Otsubo, Ayana Kon, Masao Nagasaki,[...]. Nature 2011
33

Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance.
Rangit Vallapureddy, Terra L Lasho, Katherine Hoversten, Christy M Finke, Rhett Ketterling, Curtis Hanson, Naseema Gangat, Ayalew Tefferi, Mrinal M Patnaik. Am J Hematol 2017
19
33

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
M Meggendorfer, U Bacher, T Alpermann, C Haferlach, W Kern, C Gambacorti-Passerini, T Haferlach, S Schnittger. Leukemia 2013
126
33

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
Chiara Elena, Anna Gallì, Esperanza Such, Manja Meggendorfer, Ulrich Germing, Ettore Rizzo, Jose Cervera, Elisabetta Molteni, Annette Fasan, Esther Schuler,[...]. Blood 2016
166
33

Clinical and prognostic features of patients with myelodysplastic/myeloproliferative syndrome categorized as unclassified (MDS/MPD-U) by WHO classification.
Laura Cannella, Massimo Breccia, Roberto Latagliata, Annamaria Frustaci, Giuliana Alimena. Leuk Res 2008
25
33

Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome.
Vikas Madan, Deepika Kanojia, Jia Li, Ryoko Okamoto, Aiko Sato-Otsubo, Alexander Kohlmann, Masashi Sanada, Vera Grossmann, Janani Sundaresan, Yuichi Shiraishi,[...]. Nat Commun 2015
139
33

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents.
Jane Merlevede, Nathalie Droin, Tingting Qin, Kristen Meldi, Kenichi Yoshida, Margot Morabito, Emilie Chautard, Didier Auboeuf, Pierre Fenaux, Thorsten Braun,[...]. Nat Commun 2016
142
33


Atypical Chronic Myeloid Leukemia: Where Are We Now?
Elena Crisà, Maura Nicolosi, Valentina Ferri, Chiara Favini, Gianluca Gaidano, Andrea Patriarca. Int J Mol Sci 2020
12
33

Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.
Mrinal M Patnaik, Terra L Lasho, Christy M Finke, Curtis A Hanson, Rebecca L King, Rhett P Ketterling, Naseema Gangat, Ayalew Tefferi. Am J Hematol 2016
54
33

Age-related mutations and chronic myelomonocytic leukemia.
C C Mason, J S Khorashad, S K Tantravahi, T W Kelley, M S Zabriskie, D Yan, A D Pomicter, K R Reynolds, A M Eiring, Z Kronenberg,[...]. Leukemia 2016
96
33

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.
Thomas Ernst, Andrew J Chase, Joannah Score, Claire E Hidalgo-Curtis, Catherine Bryant, Amy V Jones, Katherine Waghorn, Katerina Zoi, Fiona M Ross, Andreas Reiter,[...]. Nat Genet 2010
847
33


Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations.
Vera Adema, María J Larráyoz, María J Calasanz, Laura Palomo, Ana Patiño-García, Xabier Agirre, Jesús M Hernández-Rivas, Eva Lumbreras, Ismael Buño, Carolina Martinez-Laperche,[...]. Br J Haematol 2015
10
33

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
Rocco Piazza, Simona Valletta, Nils Winkelmann, Sara Redaelli, Roberta Spinelli, Alessandra Pirola, Laura Antolini, Luca Mologni, Carla Donadoni, Elli Papaemmanuil,[...]. Nat Genet 2013
266
33

Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study.
Sophie Vantyghem, Pierre Peterlin, Sylvain Thépot, Audrey Ménard, Viviane Dubruille, Camille Debord, Thierry Guillaume, Alice Garnier, Amandine Le Bourgeois, Soraya Wuilleme,[...]. Haematologica 2021
7
33

SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
F Damm, R Itzykson, O Kosmider, N Droin, A Renneville, V Chesnais, V Gelsi-Boyer, S de Botton, N Vey, C Preudhomme,[...]. Leukemia 2013
91
33

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.
Eunhee Kim, Janine O Ilagan, Yang Liang, Gerrit M Daubner, Stanley C-W Lee, Aravind Ramakrishnan, Yue Li, Young Rock Chung, Jean-Baptiste Micol, Michele E Murphy,[...]. Cancer Cell 2015
345
33

Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.
Xavier Calvo, Nieves Garcia-Gisbert, Ivonne Parraga, Joan Gibert, Lourdes Florensa, Marcio Andrade-Campos, Brayan Merchan, Sara Garcia-Avila, Sara Montesdeoca, Concepción Fernández-Rodríguez,[...]. Blood Adv 2020
9
33

Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.
Aurélie Caye, Marion Strullu, Fabien Guidez, Bruno Cassinat, Steven Gazal, Odile Fenneteau, Elodie Lainey, Kazem Nouri, Saeideh Nakhaei-Rad, Radovan Dvorsky,[...]. Nat Genet 2015
108
33

Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations.
Yuka Sugimoto, Hideki Muramatsu, Hideki Makishima, Courtney Prince, Anna M Jankowska, Nao Yoshida, Yinyan Xu, Nobuhiro Nishio, Asahito Hama, Hiroshi Yagasaki,[...]. Br J Haematol 2010
51
33


Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients.
Giacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, Christy M Finke, Prateek Pophali, Ryan Carr, Naseema Gangat, Moritz Binder, Animesh Pardanani, Martin Fernandez-Zapico,[...]. Leukemia 2020
47
33

Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias.
E Schuler, M Schroeder, J Neukirchen, C Strupp, B Xicoy, A Kündgen, B Hildebrandt, R Haas, N Gattermann, U Germing. Leuk Res 2014
49
33

Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.
Mrinal M Patnaik, Rangit Vallapureddy, Fevzi F Yalniz, Curtis A Hanson, Rhett P Ketterling, Terra L Lasho, Christy Finke, Aref Al-Kali, Naseema Gangat, Ayalew Tefferi. Am J Hematol 2018
40
33

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.
M M Patnaik, R Itzykson, T L Lasho, O Kosmider, C M Finke, C A Hanson, R A Knudson, R P Ketterling, A Tefferi, E Solary. Leukemia 2014
189
33

Somatic SETBP1 mutations in myeloid malignancies.
Hideki Makishima, Kenichi Yoshida, Nhu Nguyen, Bartlomiej Przychodzen, Masashi Sanada, Yusuke Okuno, Kwok Peng Ng, Kristbjorn O Gudmundsson, Bandana A Vishwakarma, Andres Jerez,[...]. Nat Genet 2013
183
33

Vascular events and risk factors for thrombosis in refractory anemia with ring sideroblasts and thrombocytosis.
M M Patnaik, T L Lasho, C M Finke, C A Hanson, R L King, R P Ketterling, N Gangat, A Tefferi. Leukemia 2016
18
33

Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations.
Sabine Jeromin, Torsten Haferlach, Sandra Weissmann, Manja Meggendorfer, Christiane Eder, Niroshan Nadarajah, Tamara Alpermann, Alexander Kohlmann, Wolfgang Kern, Claudia Haferlach,[...]. Haematologica 2015
53
33

How I treat chronic myelomonocytic leukemia.
Eric Solary, Raphael Itzykson. Blood 2017
66
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.